famotidine
NDC 83324-003, famotidine, tablet, film coated, from CHAIN DRUG MARKETING ASSOCIATION, INC..
- Product NDC
- 83324-003
- Status
- Listed
- Labeler
- CHAIN DRUG MARKETING ASSOCIATION, INC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA215766
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83324-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE10 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83324-003-30 | 83324000330 | 1 CONTAINER in 1 CARTON (83324-003-30) / 30 TABLET, FILM COATED in 1 CONTAINER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83324-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83324-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83324-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.